These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 3032112

  • 1. [Usefulness of caerulein in suppressing post-TAE complications of the gallbladder].
    Akamatsu K, Miyauchi S, Yasuhara Y, Mogami H, Nishimura N, Ohshima K, Ohta Y.
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1094-9. PubMed ID: 3032112
    [Abstract] [Full Text] [Related]

  • 2. Alleviation of gallbladder complications by treatment of hepatic arterial embolization with caerulein.
    Akamatsu K, Miyauchi S, Ohshima K, Okita S, Yasuhara Y, Mogami H, Ohta Y, Hamamoto K.
    Cancer Chemother Pharmacol; 1989 Apr; 23 Suppl():S59-64. PubMed ID: 2538268
    [Abstract] [Full Text] [Related]

  • 3. Gallbladder infarction following hepatic transcatheter arterial embolization. Angiographic study.
    Kuroda C, Iwasaki M, Tanaka T, Tokunaga K, Hori S, Yoshioka H, Nakamura H, Sakurai M, Okamura J.
    Radiology; 1983 Oct; 149(1):85-9. PubMed ID: 6310685
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Acute pancreatitis after transcatheter arterial embolization (TAE) for hepatocellular carcinoma.
    Kishimoto W, Nakao A, Takagi H, Hayakawa T.
    Am J Gastroenterol; 1989 Nov; 84(11):1396-9. PubMed ID: 2479261
    [Abstract] [Full Text] [Related]

  • 6. [Usefulness of partial splenic embolization (PSE) in hepatocellular carcinomas showing a risk of gastrointestinal bleeding after transcatheter arterial embolization (TAE)].
    Ohmoto K, Yamamoto R, Yamamoto S, Ideguchi S, Saito I, Wada A, Takatori K, Ohumi T, Hino K, Hirano Y.
    Gan No Rinsho; 1989 May; 35(6):690-5. PubMed ID: 2542638
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M, Yoshida H, Obi S, Sato S, Koike Y, Fujishima T, Tateishi R, Imamura M, Hamamura K, Teratani T, Shiina S, Ishikawa T, Omata M.
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [Abstract] [Full Text] [Related]

  • 8. Hepatic perfusion index in evaluating treatment effect of transcatheter hepatic artery embolization in patients with hepatocellular carcinoma.
    Lin WY, Wang SJ, Yeh SH.
    Neoplasma; 1995 Dec; 42(2):89-92. PubMed ID: 7617083
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS].
    Shibata H, Sogabe M, Tsutsui A, Yokoi T, Morimoto M, Fukuda T, Hayashi S, Muguruma N, Ohkita Y, Okahisa T, Okamura S, Ito S.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():133-40. PubMed ID: 9512701
    [Abstract] [Full Text] [Related]

  • 11. [The change of hepatic energy status after transcatheter arterial embolization (TAE) for hepatocellular carcinoma--a study using 31P-MRS].
    Taniguchi K, Kaminaga T, Sakon M, Umeshita K, Yamada T, Takeda Y, Higaki N, Aoki T, Ohzato H, Hasuike Y, Gotoh M, Murakami T, Nakamura H, Monden M.
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1632-4. PubMed ID: 9382494
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case.
    Sakamoto Y, Kita Y, Takayama T, Kawauchi N, Minagawa M, Makuuchi M.
    Hepatogastroenterology; 1999 Sep; 46(25):453-6. PubMed ID: 10228840
    [Abstract] [Full Text] [Related]

  • 14. [Transcatheter arterial chemoembolization and selective hepatic arterial infusion using totally implantable reservoir].
    Sakurai Y, Kodaira S, Teramoto T, Miyajima N, Kuzuoka M, Ishii T, Arisawa Y, Takabayashi T, Abe O.
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2473-8. PubMed ID: 3415258
    [Abstract] [Full Text] [Related]

  • 15. [Clinical study of porous gelatin sphere (YM 670) in transcatheter arterial embolization].
    Yamada R, Sawada S, Uchida H, Kumazaki T, Hiramatsu K, Ishii H, Nakao N, Nakamura H, Taguchi T.
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1431-6. PubMed ID: 16227743
    [Abstract] [Full Text] [Related]

  • 16. [Outcome of TAE for hepatocellular carcinoma: comparative study of SMANCS-TAE and non-SMANCS/LpTAE].
    Itsubo M, Koike K, Toda G.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():84-9. PubMed ID: 9512694
    [Abstract] [Full Text] [Related]

  • 17. [Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
    Motohara T, Ozawa Z, Morita S.
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2645-8. PubMed ID: 7979426
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic efficacy of transcatheter arterial embolization of primary hepatocellular carcinoma: discrepancy in different histopathologic subtypes.
    Wang Y, Zhang J, Gao Y, Yu M, Gong Y, Yu G.
    Chin Med J (Engl); 1999 Mar; 112(3):264-8. PubMed ID: 11593564
    [Abstract] [Full Text] [Related]

  • 19. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
    Takano S, Watanabe Y, Ohishi H, Kono S, Nakamura M, Kubota N, Iwai S.
    Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.